With the Rare Cancers Bill reaching its third reading in the House of Commons on Friday, and with hope and expectation that the Bill will pass that stage, today Dr Scott Arthur and his supporters were at the House of Lords meeting members of the Upper House, to prepare, inform and guide them through the Bill.
Advocates of the Bill, amongst which were representatives of Brain Tumour Research, joined Dr Arthur (pictured above centre) in conversations with members of the House, including Lord Sharpe of Epsom (pictured above left, with Dr Arthur on the left and Brain Tumour Research's Hugh Adams on the right), Baroness Finlay (pictured above right, centre) and Baroness Sugg (pictured above right, second from left).
Lord Sharpe has himself experienced the devastating impact of a brain tumour, when his son, Charlie Sharpe, was diagnosed with a germinoma in 2019, while in his early twenties.
The reason for these stringent preparations is that, after the third reading in the Commons, the Bill is passed over to the House of Lords to go through the repeat process there. So, there will be three further readings plus a Committee Stage. If that is all completed smoothly then the Bill comes back to the Commons for any amends to be made before it is set for Royal Assent. Today’s drop-in was sponsored by Lord Moylan, to whom we are extremely grateful.
Help us to keep pushing our agenda and campaign with us.
Related reading:
